[Naturopathic therapy for acute otitis media. An alternative to the primary use of antibiotics].
BACKGROUND
First line antibiotic treatment of uncomplicated acute otitis media has been questioned.


METHODS
In an prospective, open, controlled study, 390 children aged 1-10 years were treated either conventionally (free combinations of decongestant nose drops, mucolytics, analgesics and antibiotics) or alternatively with Otovowen, supplemented by conventional medications when considered necessary.


RESULTS
Patients treated conventionally took more antibiotics (80.5% vs 14.4%) and analgesics (66.8% vs 53.2%). The time to recovery (5.3 vs 5.1 days) and absence from school or pre-school nursery (both 1.7 days) were not significantly different between groups. Pain resolution was slightly better with conventional treatment (-5.8 vs -5.2 score points). The alternative treatment was judged both by doctors, and parents, to be significantly better tolerated.


CONCLUSIONS
In uncomplicated acute otitis media of childhood, an alternative treatment strategy with the natural medicine Otovowen may substantially reduce the use of antibiotics without disadvantage to the clinical outcome.
Wustrow
T P U
TP
HNO-Gemeinschaftspraxis, München. wustrowt@gmx.de
D000208:Acute Disease; D000700:Analgesics / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D015897:Comorbidity; D004433:Earache / Q000453:epidemiology / Q000517:prevention & control; D005260:Female; D005858:Germany / Q000453:epidemiology; D006801:Humans; D007223:Infant; D008297:Male; D009324:Naturopathy / Q000379:methods* / Q000706:statistics & numerical data; D010033:Otitis Media / Q000453:epidemiology / Q000628:therapy*; D008517:Phytotherapy / Q000379:methods / Q000706:statistics & numerical data; D010936:Plant Extracts / Q000627:therapeutic use*; D015995:Prevalence; D011320:Primary Health Care / Q000379:methods / Q000706:statistics & numerical data*; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000700:Analgesics; D000900:Anti-Bacterial Agents; C487386:Otovowen; D010936:Plant Extracts